|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-IOR-16010168 |
|
Date of registration:
|
2016-12-15 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Propofol-remifetanyl vs dexmedetomidine continous infusion for deep brain stimulation implantation
|
|
Scientific title:
|
Propofol-remifetanyl vs dexmedetomidine continous infusion for deep brain stimulation implantation |
|
Date of first enrolment:
|
2016-12-20 |
|
Target sample size:
|
propofol-remifentanyl group:25;dexmedetomidine group:25; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=15510 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Other
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Li Yu
|
|
Address:
|
37 Guoxuexiang, Chengdu, China
610041
|
|
Telephone:
|
+86 18980601545 |
|
Email:
|
biaojieli@tom.com |
|
Affiliation:
|
West China Hospital, Sichuan University |
|
|
Name:
|
Yang Yaoxin
|
|
Address:
|
37 Guoxuexiang, Chengdu, China
610041
|
|
Telephone:
|
+86 13699495092 |
|
Email:
|
yaoxin_901124@163.com |
|
Affiliation:
|
West China Hospital, Sichuan University |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients aged=18 years, ASA physical status I-III, undergoing selective deep brain stimulation, agree to inform consent and follow-up
Exclusion criteria: Patients with body mass index (BMI)> 30kg/m2 or <17 kg/m2, difficult airways such as OSAHS, head injury, intracranial hypertension, coma and other central nervous system diseases, mental disorders and communicated. Severe hypertension patients (systolic blood pressure>180mmHg and / or diastolic blood pressure> 110mmHg). Severe cardiovascular disease and patients known or suspected allergy to anesthetics (propofol, remifentanil, dexmedetomidine and so on).
Age minimum:
18
Age maximum:
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson's Disease
|
|
Intervention(s)
|
|
propofol-remifentanyl group:propofol-remifentany infusion for monitored anesthesia care during awake deep brain stimulation surgery;dexmedetomidine group:dexmedetomidine infusion for monitored anesthesia care during awake deep brain stimulation surgery;
|
|
Primary Outcome(s)
|
|
the ability of patient to cooperate in macrostimulation testing;Modified OAA/S scale;Postoperative relief of disease in patients;
|
|
Secondary Outcome(s)
|
|
VAS pain scores;Total postoperative consumption of analgesic,in mg,of through 24 hours;the incidence of vomiting and nause in the first 24h after operation;
|
|
Source(s) of Monetary Support
|
|
no
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|